Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Singh, Tej Pratap ^a   Zhang, Howard H ^a   Borek, Izabela ^b   Wolf, Peter ^b   Hedrick, Michael N ^a   Singh, Satya P ^a   Kelsall, Brian L ^a   Clausen, Bjorn E ^c   Farber, Joshua M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; FLT3 LIGAND; IMIQUIMOD; INTERLEUKIN 1BETA; INTERLEUKIN 23; TUMOR NECROSIS FACTOR; AMINOQUINOLINE DERIVATIVE; FLT3 LIGAND PROTEIN; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN;

BIOLOGICAL DEVELOPMENT; BLOOD; CELLS AND CELL COMPONENTS; GENE EXPRESSION; PHYSIOLOGY; SKIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DERMATITIS; DERMIS; EPIDERMIS; LANGERHANS CELL; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; SKIN CELL; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMICALLY INDUCED; CLASSIFICATION; CYTOLOGY; DRUG EFFECT; DRUG ERUPTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; DENDRITIC CELLS; DRUG ERUPTIONS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-23; LANGERHANS CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MONOCYTES; PSORIASIS; SKIN;

EID: 85019610985     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13581     Document Type: Article

References (69)

1. Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604 (2013).
2. Malissen, B., Tamoutounour, S. & Henri, S. The origins and functions of dendritic cells and macrophages in the skin. Nat. Rev. Immunol. 14, 417-428 (2014).
3. Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392-404 (2014).
4. Sere, K. et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 37, 905-916 (2012).
5. Ginhoux, F. et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7, 265-273 (2006).
6. Ingersoll, M. A., Platt, A. M., Potteaux, S. & Randolph, G. J. Monocyte trafficking in acute and chronic inflammation. Trends. Immunol. 32, 470-477 (2011).
7. Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227-255 (2014).
8. Zaba, L. C. et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129, 79-88 (2009).
9. Zaba, L. C., Krueger, J. G. & Lowes, M. A. Resident and "inflammatory" dendritic cells in human skin. J. Invest. Dermatol. 129, 302-308 (2009).
10. Tonel, G. et al. Cutting edge: a critical functional role for IL-23 in psoriasis. J. Immunol. 185, 5688-5691 (2010).
11. Rizzo, H. L. et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J. Immunol. 186, 1495-1502 (2011).
12. Singh, T. P., Lee, C. H. & Farber, J. M. Chemokine receptors in psoriasis. Expert Opin. Ther. Targets 17, 1405-1422 (2013).
13. Riol-Blanco, L. et al. Nociceptive sensory neurons drive interleukin-23- mediated psoriasiform skin inflammation. Nature 510, 157-161 (2014).
14. Yoshiki, R. et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing gammadelta T cells. J. Invest. Dermatol. 134, 1912-1921 (2014).
15. Kopp, T. et al. Clinical improvement in psoriasis with specific targeting of interleukin-23. Nature 521, 222-226 (2015).
16. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
17. Hedrick, M. N. et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119, 2317-2329 (2009).
18. Flutter, B. & Nestle, F. O. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur. J. Immunol. 43, 3138-3146 (2013).
19. Suarez-Farinas, M. et al. Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation. PLoS ONE 8, e84634 (2013).
20. Cai, Y. et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35, 596-610 (2011).
21. Reich, K. et al. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J. Invest. Dermatol. 118, 155-163 (2002).
22. Uribe-Herranz, M., Lian, L. H., Hooper, K. M., Milora, K. A. & Jensen, L. E. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation. J. Invest. Dermatol. 133, 1541-1549 (2013).
23. Dieu-Nosjean, M. C. et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192, 705-718 (2000).
24. Hedrick, M. N., Lonsdorf, A. S., Hwang, S. T. & Farber, J. M. CCR6 as a possible therapeutic target in psoriasis. Expert Opin. Ther. Targets 14, 911-922 (2010).
25. Kim, T. G. et al. Dermal clusters of mature dendritic cells and T cells are associated with the CCL20/CCR6 chemokine system in chronic psoriasis. J. Invest. Dermatol. 134, 1462-1465 (2014).
26. Le Borgne, M. et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8p T cell crosspriming in vivo. Immunity 24, 191-201 (2006).
27. Nagao, K. et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat. Immunol. 13, 744-752 (2012).
28. Singh, S. P., Zhang, H. H., Foley, J. F., Hedrick, M. N. & Farber, J. M. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180, 214-221 (2008).
29. Vanbervliet, B. et al. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 32, 231-242 (2002).
30. Homey, B. et al. Up-regulation of macrophage inflammatory protein-3 alpha/ CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000).
31. Mabuchi, T. et al. CCR6 is required for epidermal trafficking of gammadelta-T cells in an IL-23-induced model of psoriasiform dermatitis. J. Invest. Dermatol. 133, 164-171 (2013).
32. Jakubzick, C. et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 39, 599-610 (2013).
33. Tamoutounour, S. et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39, 925-938 (2013).
34. Awasthi, A. et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182, 5904-5908 (2009).
35. Henri, S. et al. CD207p CD103p dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207, 189-206 (2010).
36. Schwarz, A. et al. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 130, 1419-1427 (2010).
37. Larregina, A. T. et al. Dermal-resident CD14(p) cells: differentiate into Langerhans cells. Nat. Immunol. 2, 1151-1158 (2001).
38. Chan, J. R. et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
39. Segura, E. & Amigorena, S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 34, 440-445 (2013).
40. Gray, E. E., Suzuki, K. & Cyster, J. G. Cutting edge: Identification of a motile IL-17-producing gammadelta T cell population in the dermis. J. Immunol. 186, 6091-6095 (2011).
41. Kucharzik, T., Hudson, 3rd J. T., Waikel, R. L., Martin, W. D. & Williams, I. R. CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse. Eur. J. Immunol. 32, 104-112 (2002).
42. Lowes, M. A. et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl Acad. Sci. USA 102, 19057-19062 (2005).
43. Hansel, A. et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J. Allergy Clin. Immunol. 127, e781-e789 (2011).
44. Pantelyushin, S. et al. Rorgammatp innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252-2256 (2012).
45. Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585-600 (2014).
46. Wu, J. K., Siller, G. & Strutton, G. Psoriasis induced by topical imiquimod. Australas J. Dermatol. 45, 47-50 (2004).
47. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
48. Wohn, C. et al. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc. Natl Acad. Sci. USA 110, 10723-10728 (2013).
49. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. & Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10, 864-871 (2009).
50. Chopin, M. et al. Langerhans cells are generated by two distinct PU.1- dependent transcriptional networks. J. Exp. Med. 210, 2967-2980 (2013).
51. Bromley, S. K., Larson, R. P., Ziegler, S. F. & Luster, A. D. IL-23 induces atopic dermatitis-like inflammation instead of psoriasis-like inflammation in CCR2-deficient mice. PLoS ONE 8, e58196 (2013).
52. Rivollier, A., He, J., Kole, A., Valatas, V. & Kelsall, B. L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155 (2012).
53. Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023-1034 (2011).
54. Zaba, L. C. et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204, 3183-3194 (2007).
55. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950-957 (2007).
56. Harper, E. G. et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 129, 2175-2183 (2009).
57. Salazar-Gonzalez, R. M. et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24, 623-632 (2006).
58. Manthey, H. D. et al. CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb. Haemost. 110, 1267-1277 (2013).
59. Wan, W. et al. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice. Circ. Res. 109, 374-381 (2011).
60. Chen, L., Zhang, Z., Barletta, K. E., Burdick, M. D. & Mehrad, B. Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors. Am. J. Physiol. Lung Cell Mol. Physiol. 305, L702-L711 (2013).
61. Ravindran, R., Rusch, L., Itano, A., Jenkins, M. K. & McSorley, S. J. CCR6-dependent recruitment of blood phagocytes is necessary for rapid CD4 T cell responses to local bacterial infection. Proc. Natl Acad. Sci. USA 104, 12075-12080 (2007).
62. Ruth, J. H. et al. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest. 83, 579-588 (2003).
63. Yang, D. et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528 (1999).
64. Phadke, A. P., Akangire, G., Park, S. J., Lira, S. A. & Mehrad, B. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am. J. Respir. Crit. Care Med. 175, 1165-1172 (2007).
65. Provoost, S., Maes, T., Joos, G. F. & Tournoy, K. G. Monocyte-derived dendritic cell recruitment and allergic T(H)2 responses after exposure to diesel particles are CCR2 dependent. J. Allergy Clin. Immunol. 129, 483-491 (2012).
66. Lundy, S. K. et al. Attenuation of allergen-induced responses in CCR6-/- mice is dependent upon altered pulmonary T lymphocyte activation. J. Immunol. 174, 2054-2060 (2005).
67. Bracke, K. R. et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J. Immunol. 177, 4350-4359 (2006).
68. Siddiqui, K. R., Laffont, S. & Powrie, F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 32, 557-567 (2010).
69. Bennett, C. L. et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576 (2005).